Specific niche view of the structured sector hierarchy. Useful for precedent work where broader sector slices include too much noise.
| Target | Buyer / Investor | Sector | Geo | Transaction size | EV / EBITDA |
|---|---|---|---|---|---|
| Proscia | Agilent Technologies | Medical & Diagnostic Laboratories | $240M | n/m | |
| Blackford Analysis | Azra AI, Sopris Capital | Medical & Diagnostic Laboratories | $42.0M – $56.0M | 11× – 14× | |
| Myriad Genetics Prenatal Health testing business | Labcorp | Medical & Diagnostic Laboratories | $210M | 6× – 7× | |
| TechScan, Inc. | Palmetto Air & Water Balance, LLC | Medical & Diagnostic Laboratories | $10.1M – $13.7M | 6× – 8× | |
| select assets of BioReference Health | Labcorp Holdings Inc. | Medical & Diagnostic Laboratories | $722M | 11× – 15× | |
| BioReference Health, LLC | Labcorp | Medical & Diagnostic Laboratories | $722M | 14× – 18× | |
| Blackford Analysis | Sopris Capital | Medical & Diagnostic Laboratories | $26.0M – $35.0M | 9× – 12× | |
| SN Genelab | Dr Lal PathLabs | Medical & Diagnostic Laboratories | $0.0M | 7× – 10× | |
| Lifeanalytics | Eurofins Scientific | Medical & Diagnostic Laboratories | $45.1M – $59.9M | 6× – 8× | |
| MLM Medical Labs | Labcorp | Medical & Diagnostic Laboratories | $150M – $200M | 10× – 14× |
Bins are observed deal frequencies across disclosed transactions. Use as a directional reference, not a target valuation.
Use the directory on the recent deals hub to switch between countries, sectors and sub-sectors. A free account unlocks the structured filters that go beyond the public view.